NYSE: MMCMarsh & Mclennan Companies Inc Stock
$212.10-7.97 (-3.62%)
Updated Apr 21, 2025
MMC Price
$212.10
Fair Value Price
N/A
Market Cap
$104.51B
52 Week Low
$196.72
52 Week High
$248.00
P/E
25.8x
P/B
7.43x
P/S
4.79x
PEG
2.23x
Dividend Yield
1.16%
Revenue
$25.05B
Earnings
$4.04B
Gross Margin
100%
Operating Margin
24.59%
Profit Margin
16.1%
Debt to Equity
3.04
Operating Cash Flow
$4B
Beta
0.67
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MMC Overview
Marsh & McLennan Companies, Incorporated offers insurance brokerage, reinsurance, and other risk management services, as well as health, wealth, career consulting, and economic and brand consulting services and products. Its four main operating companies are Marsh, Guy Carpenter, Mercer, and Oliver Wyman. Marsh & McLennan Companies was founded in 1871 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MMC's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Insurance
Industry Rating
A
MMC
Ranked#12 of 14
Ranked#12 of 14
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.22 | A | |
| $110.17 | B | |
| $2.95 | B |
Be the first to know about important MMC news, forecast changes, insider trades & much more!
MMC News
Overview
Due Diligence Score
–
Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MMC scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MMC ($212.10) is trading above its intrinsic value of $77.67, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MMC is good value based on its earnings relative to its share price (25.8x), compared to the US market average (27.14x)
P/E vs Market Valuation
MMC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MMC due diligence checks available for Premium users.
Valuation
MMC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
25.8x
Industry
0.62x
Market
27.14x
MMC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MMC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
MMC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
7.43x
Industry
6x
MMC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MMC price to earnings growth (PEG)
For valuing profitable companies with growth potential
MMC is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
MMC's financial health
Profit margin
Revenue
$7.1B
Net Income
$1.4B
Profit Margin
19.6%
MMC's Earnings (EBIT) of $6.16B... subscribe to Premium to read more.
Interest Coverage Financials
MMC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$57.0B
Liabilities
$42.7B
Debt to equity
3.04
MMC's short-term assets ($22.46B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MMC's long-term liabilities ($22.97B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MMC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MMC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$622.0M
Investing
$26.0M
Financing
-$138.0M
MMC's operating cash flow ($4.46B)... subscribe to Premium to read more.
Debt Coverage Financials
MMC vs Insurance Stocks
Marsh & Mclennan Companies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.